DEF 14AThe Ballot
Outlook Therapeutics, Inc. files DEF 14A
Filed Aug 17, 2018 · 7y ago · Accession 0001144204-18-045240
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Outlook Therapeutics, Inc.
- Ticker
- OTLK
- CIK
- 1649989
- Form type
- DEF 14A
- Filing date
- Aug 17, 2018
- Report date
- Sep 21, 2018
- Document
- tv500398-def14a.htm
- Size
- 2.3 MB